Neoprobe's Lymphoseek Phase 2 study data published in Annals of Surgical Oncology

[News]

Neoprobe Corporation (NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that results from a Phase II study of Lymphoseek® (Tilmanocept) have been published online in the Annals of Surgical Oncology and demonstrate the tracing agent's ability to identify tumor-draining lymph nodes in breast cancer and melanoma patients.

More... (http://www.news-medical.net/news/20110225/Neoprobes-Lymphoseek-Phase-2-study-data-published-in-Annals-of-Surgical-Oncology.aspx)